Xiao Bo Lu
Directeur/Membre du Conseil chez Qingdao Raisecare Biotechnology Co., Ltd.
Postes actifs de Xiao Bo Lu
Sociétés | Poste | Début | Fin |
---|---|---|---|
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | Private Equity Investor | - | - |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | Directeur/Membre du Conseil | 12/04/2021 | - |
Qingdao Raisecare Biotechnology Co., Ltd.
Qingdao Raisecare Biotechnology Co., Ltd. Medical SpecialtiesHealth Technology Qingdao Raisecare Biotechnology Co., Ltd. is a pharmaceutical company founded in 2016. The private company is based in Qingdao, China and develops and promotes pharmaceutical chemicals and products. | Directeur/Membre du Conseil | 16/10/2020 | - |
Historique de carrière de Xiao Bo Lu
Anciens postes connus de Xiao Bo Lu
Sociétés | Poste | Début | Fin |
---|---|---|---|
INNOVITA BIOLOGICAL TECHNOLOGY CO., LTD. | Directeur/Membre du Conseil | 01/12/2019 | 24/02/2023 |
CHENGDU BRIGHT EYE HOSPITAL CO., LTD. | Directeur/Membre du Conseil | 01/12/2017 | 10/10/2022 |
BEIJING KONRUNS PHARMACEUTICAL CO.,LTD. | Directeur/Membre du Conseil | 25/06/2014 | 12/04/2022 |
QINGDAO BAHEAL MEDICAL INC. | Directeur/Membre du Conseil | 27/03/2020 | - |
TRANSCENTA HOLDING LIMITED | Directeur/Membre du Conseil | - | - |
Formation de Xiao Bo Lu
Tsinghua University | Masters Business Admin |
Zhejiang University | Undergraduate Degree |
Statistiques
Internationale
Chine | 9 |
Hong Kong | 2 |
Îles Cayman | 2 |
Opérationnelle
Director/Board Member | 7 |
Masters Business Admin | 2 |
Private Equity Investor | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 5 |
---|---|
TRANSCENTA HOLDING LIMITED | Health Technology |
QINGDAO BAHEAL MEDICAL INC. | Health Technology |
BEIJING KONRUNS PHARMACEUTICAL CO.,LTD. | Retail Trade |
INNOVITA BIOLOGICAL TECHNOLOGY CO., LTD. | Health Technology |
CHENGDU BRIGHT EYE HOSPITAL CO., LTD. | Health Services |
Entreprise privées | 3 |
---|---|
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | Finance |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | Commercial Services |
Qingdao Raisecare Biotechnology Co., Ltd.
Qingdao Raisecare Biotechnology Co., Ltd. Medical SpecialtiesHealth Technology Qingdao Raisecare Biotechnology Co., Ltd. is a pharmaceutical company founded in 2016. The private company is based in Qingdao, China and develops and promotes pharmaceutical chemicals and products. | Health Technology |
- Bourse
- Insiders
- Xiao Bo Lu
- Expérience